高雄醫學大學圖書館 |

語系/ Language: 繁體中文

登入

回首頁

The business of healthcare innovation /

Burns, Lawton R.

The business of healthcare innovation /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	The business of healthcare innovation // edited by Lawton Robert Burns.
其他作者:	Burns, Lawton R.
出版者:	Cambridge, U.K. ;Cambridge University Press, : c2020.,
版本:	3rd ed.
面頁冊數:	xxvi, 492 p. :ill. ; : 25 cm.;
提要註:	"Perhaps as never before, countries around the world are looking at biomedical innovation as a source of (a) knowledge creation by their scientific communities, (b) value creation for their populations, and (c) wealth creation by fostering industries and expansion of employment. In the U.S., for example, bipartisan passage of the 21st Century Cures Act of 2016 seeks to accelerate new product development and faster patient access to new treatments and therapies. It also elevates the role of biomedical research through an additional $6.3 billion in funding for the National Institutes of Health (NIH) and other agencies"--
標題:	Technology, Pharmaceutical - economics. -
ISBN:	9781108749060 (pbk.) :

The business of healthcare innovation /
The business of healthcare innovation /edited by Lawton Robert Burns. - 3rd ed. - Cambridge, U.K. ;Cambridge University Press,c2020. - xxvi, 492 p. :ill. ;25 cm.

Includes bibliographical references and index.

"Perhaps as never before, countries around the world are looking at biomedical innovation as a source of (a) knowledge creation by their scientific communities, (b) value creation for their populations, and (c) wealth creation by fostering industries and expansion of employment. In the U.S., for example, bipartisan passage of the 21st Century Cures Act of 2016 seeks to accelerate new product development and faster patient access to new treatments and therapies. It also elevates the role of biomedical research through an additional $6.3 billion in funding for the National Institutes of Health (NIH) and other agencies"--

ISBN: 9781108749060 (pbk.) :NT1355

LCCN: 2019039714Subjects--Topical Terms:

464535
Technology, Pharmaceutical
--economics.

LC Class. No.: R855.3 / .B87 2020

Dewey Class. No.: 610.28

National Library of Medicine Call No.: W 74.1 / B979 2020

The business of healthcare innovation /
LDR:01373cam a2200241 a 4500 001 337565
005 20210419144000.0
008 210428s2020 enka b 001 0 eng
010 $a 2019039714
020 $a 9781108749060 (pbk.) : $c NT1355
020 $a 9781108479448 (hard)
020 $a 9781108785549 (ebk.)
035 $a 00382540
040 $a KMU $d KMU
042 $a pcc
050 0 0 $a R855.3 $b .B87 2020
060 4 $a W 74.1 $b B979 2020
082 0 0 $a 610.28 $2 23
245 0 4 $a The business of healthcare innovation / $c edited by Lawton Robert Burns.
250 $a 3rd ed.
260 $a Cambridge, U.K. ; $a New York, NY : $b Cambridge University Press, $c c2020.
300 $a xxvi, 492 p. : $b ill. ; $c 25 cm.
504 $a Includes bibliographical references and index.
520 $a "Perhaps as never before, countries around the world are looking at biomedical innovation as a source of (a) knowledge creation by their scientific communities, (b) value creation for their populations, and (c) wealth creation by fostering industries and expansion of employment. In the U.S., for example, bipartisan passage of the 21st Century Cures Act of 2016 seeks to accelerate new product development and faster patient access to new treatments and therapies. It also elevates the role of biomedical research through an additional $6.3 billion in funding for the National Institutes of Health (NIH) and other agencies"-- $c Provided by publisher.
650 2 2 $a Technology, Pharmaceutical $x economics. $3 464535
650 2 2 $a Equipment and Supplies $x economics. $3 464534
650 2 2 $a Biotechnology $x economics. $3 464533
650 1 2 $a Health Care Sector. $3 435719
650 1 2 $a Diffusion of Innovation. $3 301831
650 0 $a Economic forecasting. $3 309904
650 0 $a Business forecasting. $3 294234
650 0 $a Medical technology $x Economic aspects. $3 464532
650 0 $2 96060 $a Medical care $x Technological innovations. $3 242901
700 1 $a Burns, Lawton R. $3 323680